South Korea · Delayed Price · Currency is KRW Bioneer Statistics
Total Valuation
Bioneer has a market cap or net worth of KRW 198.22 billion. The enterprise value is 224.60 billion.
| Market Cap | 198.22B |
| Enterprise Value | 224.60B |
Important Dates
The next estimated earnings date is Friday, August 14, 2026.
| Earnings Date | Aug 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Bioneer has 25.81 million shares outstanding. The number of shares has increased by 1.01% in one year.
| Current Share Class | 25.81M |
| Shares Outstanding | 25.81M |
| Shares Change (YoY) | +1.01% |
| Shares Change (QoQ) | +0.06% |
| Owned by Insiders (%) | 18.61% |
| Owned by Institutions (%) | 4.30% |
| Float | 21.00M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.59 |
| PB Ratio | 0.91 |
| P/TBV Ratio | 0.98 |
| P/FCF Ratio | 21.13 |
| P/OCF Ratio | 15.40 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.69, with an EV/FCF ratio of 23.94.
| EV / Earnings | n/a |
| EV / Sales | 0.66 |
| EV / EBITDA | 11.69 |
| EV / EBIT | 21.69 |
| EV / FCF | 23.94 |
Financial Position
The company has a current ratio of 2.04, with a Debt / Equity ratio of 0.49.
| Current Ratio | 2.04 |
| Quick Ratio | 1.43 |
| Debt / Equity | 0.49 |
| Debt / EBITDA | 5.56 |
| Debt / FCF | 11.39 |
| Interest Coverage | 2.26 |
Financial Efficiency
Return on equity (ROE) is -1.00% and return on invested capital (ROIC) is -1.90%.
| Return on Equity (ROE) | -1.00% |
| Return on Assets (ROA) | 1.76% |
| Return on Invested Capital (ROIC) | -1.90% |
| Return on Capital Employed (ROCE) | 3.51% |
| Weighted Average Cost of Capital (WACC) | 2.27% |
| Revenue Per Employee | 921.01M |
| Profits Per Employee | -15.91M |
| Employee Count | 367 |
| Asset Turnover | 0.92 |
| Inventory Turnover | 2.00 |
Taxes
In the past 12 months, Bioneer has paid 7.36 billion in taxes.
| Income Tax | 7.36B |
| Effective Tax Rate | 143.45% |
Stock Price Statistics
The stock price has decreased by -52.88% in the last 52 weeks. The beta is 0.05, so Bioneer's price volatility has been lower than the market average.
| Beta (5Y) | 0.05 |
| 52-Week Price Change | -52.88% |
| 50-Day Moving Average | 9,864.00 |
| 200-Day Moving Average | 12,501.80 |
| Relative Strength Index (RSI) | 32.77 |
| Average Volume (20 Days) | 285,369 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Bioneer had revenue of KRW 338.01 billion and -5.84 billion in losses. Loss per share was -225.08.
| Revenue | 338.01B |
| Gross Profit | 261.31B |
| Operating Income | 10.36B |
| Pretax Income | 5.13B |
| Net Income | -5.84B |
| EBITDA | 19.22B |
| EBIT | 10.36B |
| Loss Per Share | -225.08 |
Balance Sheet
The company has 93.25 billion in cash and 106.85 billion in debt, with a net cash position of -13.60 billion or -526.81 per share.
| Cash & Cash Equivalents | 93.25B |
| Total Debt | 106.85B |
| Net Cash | -13.60B |
| Net Cash Per Share | -526.81 |
| Equity (Book Value) | 218.22B |
| Book Value Per Share | 7,954.93 |
| Working Capital | 76.42B |
Cash Flow
In the last 12 months, operating cash flow was 12.88 billion and capital expenditures -3.50 billion, giving a free cash flow of 9.38 billion.
| Operating Cash Flow | 12.88B |
| Capital Expenditures | -3.50B |
| Depreciation & Amortization | 8.86B |
| Net Borrowing | -3.13B |
| Free Cash Flow | 9.38B |
| FCF Per Share | 363.43 |
Margins
Gross margin is 77.31%, with operating and profit margins of 3.06% and -1.73%.
| Gross Margin | 77.31% |
| Operating Margin | 3.06% |
| Pretax Margin | 1.52% |
| Profit Margin | -1.73% |
| EBITDA Margin | 5.69% |
| EBIT Margin | 3.06% |
| FCF Margin | 2.78% |
Dividends & Yields
Bioneer does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.01% |
| Shareholder Yield | -1.01% |
| Earnings Yield | -2.94% |
| FCF Yield | 4.73% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Bioneer has an Altman Z-Score of 3.2 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.2 |
| Piotroski F-Score | 6 |